We are live on
!
Find out more
ECP
Elk Creek Partners Portfolio holdings
AUM
$582M
Turnover
14.71%
1-Year Est. Return
10.23%
This Fund
S&P 500
This Quarter
Est. Return
-24.86%
1 Year Est. Return
-10.23%
3 Year Est. Return
+16.39%
5 Year Est. Return
+41.52%
10 Year Est. Return
–
AUM
$582M
AUM Growth
-$287M
(-33%)
Cap. Flow
+$8.91M
Cap. Flow
% of AUM
1.53%
Top 10 Holdings %
Top 10 Hldgs %
27.67%
Holding
102
New
10
Increased
40
Reduced
47
Closed
5
Avg Time Held
2.1
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$9.44M |
| 2 |
iShares Russell 2000 Growth ETF
IWO
|
+$9.41M |
| 3 |
Cutera, Inc.
CUTR
|
+$8.99M |
| 4 |
Primo Water Corporation
PRMW
|
+$8.71M |
| 5 |
Intra-Cellular Therapies Inc.
ITCI
|
+$5.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
INXN
Interxion Holding N.V.
INXN
|
+$26.2M |
| 2 |
WAAS
AquaVenture Holdings Limited
WAAS
|
+$11.2M |
| 3 |
WMGI
Wright Medical Group Inc
WMGI
|
+$9.95M |
| 4 |
STMP
Stamps.com, Inc.
STMP
|
+$8.37M |
| 5 |
LMNX
Luminex Corp
LMNX
|
+$7.82M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 40.52% |
| 2 | Technology | 18.63% |
| 3 | Industrials | 10.61% |
| 4 | Consumer Discretionary | 8.24% |
| 5 | Financials | 7.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Cerus
CERS
$451M
| $29M | 4.98% |
6,236,683
+952,242
| +18% | +$4.31M |
2014 Q1
24 quarters
|
|
|
QUOT
2
DELISTED
Quotient Technology Inc
QUOT
| $20.7M | 3.55% |
3,178,811
-42,605
| -1% | -$381K |
2016 Q2
15 quarters
|
|
3
Ligand Pharmaceuticals
LGND
$5.88B
| $17.9M | 3.08% |
394,740
+15,050
| +4% | +$853K |
2016 Q3
14 quarters
|
|
4
OneSpan
OSPN
$648M
| $16.2M | 2.77% |
890,215
-11,574
| -1% | -$196K |
2015 Q2
19 quarters
|
|
5
DELISTED
Infinera Corporation Common Stock
INFN
| $15.3M | 2.62% |
2,878,133
+259,147
| +10% | +$1.78M |
2016 Q2
15 quarters
|
|
|
IVC
6
DELISTED
Invacare Corporation
IVC
| $13.7M | 2.35% |
1,843,320
-24,076
| -1% | -$187K |
2017 Q2
11 quarters
|
|
7
Karyopharm Therapeutics
KPTI
$7.14M
| $13.4M | 2.31% |
46,663
+15,976
| +52% | +$4.41M |
2019 Q3
2 quarters
|
|
8
Iridium Communications
IRDM
$4.85B
| $11.8M | 2.02% |
528,007
-7,080
| -1% | -$183K |
2013 Q4
25 quarters
|
|
9
Halozyme
HALO
$13.3B
| $11.8M | 2.02% |
654,362
+15,492
| +2% | +$294K |
2018 Q3
6 quarters
|
|
10
DELISTED
Synchronoss Technologies
SNCR
| $11.4M | 1.96% |
416,249
-201
| -0% | -$8.85K |
2018 Q4
5 quarters
|
|
11
Evolent Health
EVH
$535M
| $10.6M | 1.81% |
1,944,309
+2,275
| +0.1% | +$20.3K |
2015 Q2
19 quarters
|
|
12
Healthcare Services Group
HCSG
$1.44B
| $10.5M | 1.81% |
440,191
-5,904
| -1% | -$152K |
2018 Q2
7 quarters
|
|
13
Churchill Downs
CHDN
$5.58B
| $9.07M | 1.56% |
176,148
+13,912
| +9% | +$897K |
2013 Q4
25 quarters
|
|
|
MAXR
14
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $9.01M | 1.55% |
843,226
-192,023
| -19% | -$3M |
2019 Q1
4 quarters
|
|
15
Covista Inc
CVSA
$4.38B
| $8.97M | 1.54% |
334,996
+38,683
| +13% | +$1.23M |
2017 Q4
9 quarters
|
|
16
Pacira BioSciences
PCRX
$1.45B
| $8.89M | 1.53% |
265,146
-6,036
| -2% | -$251K |
2015 Q2
19 quarters
|
|
17
DELISTED
Amicus Therapeutics
FOLD
| $8.64M | 1.48% |
935,002
+75,696
| +9% | +$720K |
2019 Q1
4 quarters
|
|
18
Grocery Outlet
GO
$1.26B
| $8.03M | 1.38% |
233,876
+68,674
| +42% | +$2.23M |
2019 Q4
1 quarter
|
|
|
NGHC
19
DELISTED
National General Holdings Corp
NGHC
| $7.98M | 1.37% |
482,296
+26,118
| +6% | +$523K |
2014 Q4
21 quarters
|
|
|
VCRA
20
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $7.6M | 1.31% |
357,758
+5,073
| +1% | +$115K |
2019 Q1
4 quarters
|
|
|
21
iShares Russell 2000 Growth ETF
IWO
$13.5B
| $7.5M | 1.29% |
+47,399
| New | +$9.41M |
2020 Q1
0 quarters
|
|
22
MaxLinear
MXL
$7.15B
| $7.48M | 1.29% |
641,244
+89,766
| +16% | +$1.5M |
2014 Q3
22 quarters
|
|
23
Zurn Elkay Water Solutions
ZWS
$7.81B
| $7.47M | 1.28% |
684,432
-9,170
| -1% | -$134K |
2016 Q3
14 quarters
|
|
|
ICPT
24
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $7.44M | 1.28% |
118,188
+27,384
| +30% | +$2.46M |
2019 Q3
2 quarters
|
|
|
TVTY
25
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $7.42M | 1.27% |
1,178,973
+335,622
| +40% | +$5.41M |
2018 Q4
5 quarters
|
|
Similar funds
BAC
AVC
OWD
PP
WWM
GBA
JA
PL
Elk Creek Partners's Q1 2020 Portfolio in Review
As of Q1 2020, Elk Creek Partners held 102 positions worth $582M, down 33% from $870M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Elk Creek Partners's Q1 2020 filing shows 10 new, 40 increased, 47 reduced and 5 closed positions. Its largest new stake was iShares Russell 2000 ETF: 63,333 shares worth $7.25M. The largest sale was Interxion Holding N.V., an estimated $26.2M.
By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 36% a quarter earlier, followed by Technology and Industrials.
- Elk Creek Partners's largest Q1 2020 buy was iShares Russell 2000 ETF: 63,333 shares worth $7.25M.
- Elk Creek Partners added most to Tivity Health, Inc. Common Stock in Q1 2020, an estimated $5.41M increase.
- Elk Creek Partners's biggest Q1 2020 reduction was Stamps.com, Inc., cutting an estimated $8.37M.
- Elk Creek Partners fully exited Interxion Holding N.V. in Q1 2020, selling an estimated $26.2M.
- Elk Creek Partners's ten largest holdings make up 28% of its $582M portfolio in Q1 2020.
- Elk Creek Partners opened 10 new positions and closed 5 in Q1 2020.
- Elk Creek Partners's portfolio value fell 33% quarter-over-quarter to $582M.
Based on Elk Creek Partners's 13F filing for Q1 2020, filed 14 May 2020.